Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
01/2011
01/06/2011WO2011001089A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
01/06/2011WO2011001088A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
01/06/2011WO2011000945A2 Aminoalkamides for use in the treatment of inflammatory, degenerative or demyelinating diseases of the cns
01/06/2011WO2011000565A1 Eltoprazine for the treatment of anxiety
01/06/2011WO2011000564A1 Eltoprazine for the treatment of drug addiction
01/06/2011WO2011000562A1 Eltoprazine for the treatment of certain movement disorders
01/06/2011WO2011000309A1 Use of puerarin in preparing medicine for treating p2x3-mediated pain/nervous system disease
01/06/2011WO2011000104A1 Fluorinated derivatives of 3-hydroxypyridin-4-ones
01/06/2011WO2010131038A3 Steroid containing composition and uses thereof
01/06/2011WO2010130980A3 A fertilized, incubated avian egg or extract for the treatment of stress
01/06/2011WO2010130934A3 2-cycloamino-5-(pyridin-4-yl)imidazo[2,1-b][1,3,4]thiadiazole derivatives, preparation thereof, and therapeutic use thereof
01/06/2011WO2010130773A3 Benzoxazolone derivatives as aldosterone symthase inhibitors
01/06/2011WO2010122575A3 Process for the preparation of pure paliperidone
01/06/2011WO2010121225A3 Method of treating disorders associated with protein kinase ck2 activity
01/06/2011WO2010104843A3 Substituted heterocycles and their use as allosteric modulators of nicotinic and gabaa receptors
01/06/2011WO2010098600A3 Substituted azole derivatives, pharmaceutical composition containing the derivatives, and method for treating parkinson's disease using the same
01/06/2011WO2010098502A9 Imaging diagnostic agent and extracorporeal diagnostic agent for incurable neurological diseases
01/06/2011WO2010093904A3 Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf
01/06/2011WO2010090494A3 Medical use of 5-benzylaminosalicylic acid derivatives or salts thereof
01/06/2011WO2010081825A3 Pirenzepine as an agent in cancer treatment
01/06/2011WO2010056985A8 Treatment of proteinopathies using a farnesyl transferase inhibitor
01/06/2011US20110004949 Immunoglobulin 1
01/06/2011US20110004948 Immunoglobulin 2
01/06/2011US20110003987 Synthesis of udp-glucose: n-acylsphingosine glucosyltransferase inhibitors
01/06/2011US20110003870 Method of treatment of a neurological disorder
01/06/2011US20110003868 Treatment of a neuropathy with rapid release aminopyridine
01/06/2011US20110003867 Novel 2-ethyl-methyl-amino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators
01/06/2011US20110003866 Novel 2-dimethylamino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators
01/06/2011US20110003865 Novel 2-diethylamino-3-amido-6-amino-pyridine derivatives useful as potassium channel activators
01/06/2011US20110003862 3-Animopyraolines for Treatment of Neurodegenerative and Psychiatric Diseases
01/06/2011US20110003860 Hydroxyl compounds and compositions for cholesterol management and related uses
01/06/2011US20110003853 Metalloproteinase Inhibitors
01/06/2011US20110003851 Small molecule hematopoietic growth factor mimetic compounds that activate hematopoietic growth factor receptors
01/06/2011US20110003840 Pyridoindolobenzox-and thiazepine derivatives and uses thereof
01/06/2011US20110003836 Pro-Neurogenic Compounds
01/06/2011US20110003834 Production method and production apparatus for a high theobromine-containing composition
01/06/2011US20110003831 N-(-3-methoxy-5-methylpyrazin-2-yl)-2-(4-'1,3,4-oxadiazol-2-yl!phenyl)pyridine-3 sulphonamide as an anticancer agent
01/06/2011US20110003830 Process for the preparation of 3-amino-8-(1-piperazinyl)-2h-1-benzopyran-2-one and salts and solvates thereof
01/06/2011US20110003825 Substituted amide beta secretase inhibitors
01/06/2011US20110003824 Caspase Inhibitors and Uses Thereof
01/06/2011US20110003822 P2x3 receptor antagonists for treatment of pain
01/06/2011US20110003820 Pyrazolopyrimidines, a process for their preparation and their use as medicine
01/06/2011US20110003819 Methods of treating multiple sclerosis using neurotrophin mimetics
01/06/2011US20110003814 Pyrimidines useful as modulators of voltage-gated ion channels
01/06/2011US20110003813 Substituted biaryl piperazinyl-pyridine analogues
01/06/2011US20110003812 Human Adam-10 Inhibitors
01/06/2011US20110003811 Subsituted pyridine derivatives
01/06/2011US20110003810 Heterocyclic compounds and their use as glycogen synthase kinase-3 inhibitors
01/06/2011US20110003802 Bridged N-Cyclic Sulfonamido Inhibitors of Gamma Secretase
01/06/2011US20110003801 Benzimidazole derivatives useful as trpm8 channel modulators
01/06/2011US20110003800 Benzimidazole derivatives useful as trpm8 channel modulators
01/06/2011US20110003799 3,4-disubstituted 1h-pyrazole compounds and their use as cyclin dependent kinase and glycogen synthase kinase-3 modulators
01/06/2011US20110003798 Compounds and compositions as kinase inhibitors
01/06/2011US20110003797 HEXAHYDROCYCLOPENTYL[f]INDAZOLE CARBOXAMIDES AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
01/06/2011US20110003795 Substituted Aromatic Carboxamide and Urea Derivatives as Vanilloid Receptor Ligands
01/06/2011US20110003793 AZINONE-SUBSTITUTED AZEPINO[b]INDOLE AND PYRIDO-PYRROLO-AZEPINE MCH-1 ANTAGONISTS, METHODS OF MAKING, AND USE THEREOF
01/06/2011US20110003792 Anti-inflammatory agents
01/06/2011US20110003790 Pyrido [4, 3-d] pyrimidinone derivatives as kinase inhibitors
01/06/2011US20110003775 Composition and method for promoting survival of aged basal forebrain cholinergic neuron leading to provention and treatment of age-related neurodegenerative disorder
01/06/2011US20110003774 Compounds having anti-proliferative properties
01/06/2011US20110003767 Inhibitors of Acetyl-CoA Carboxylase for Treatment of Neuronal Hypometabolism
01/06/2011US20110003759 Non-basic melanin concentrating hormone receptor-1 antagonists and methods
01/06/2011US20110003756 C5a Receptor Antagonists
01/06/2011US20110003750 Human 3 relaxin
01/06/2011US20110003741 Novel neurturin conjugates for pharmaceutical use
01/06/2011US20110003739 Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
01/06/2011US20110003738 Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof
01/06/2011US20110003737 Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof
01/06/2011US20110003388 processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient; making an enhanced, autologous fat graft comprising supplementing a first portion of extracted adipose tissue with an additive and a disaggregated population of adipose-derived cells
01/06/2011US20110003009 Process for obtaining a rabbit skin comprising biological active substances
01/06/2011US20110003008 Mesenchymal stem cell particles
01/06/2011US20110003006 Orally Disintegrating Tablet Compositions Comprising Combinations of Non-Opioid and Opioid Analgesics
01/06/2011US20110002999 Biopolymer System for Tissue Sealing
01/06/2011US20110002991 Phenylethanoic acid, phenylpropanoic acid and phenylpropenoic acid conjugates and prodrugs of hydrocodone, method of making and use thereof
01/06/2011US20110002990 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof
01/06/2011US20110002989 Methods, dosage forms and kits for administering ziprasidone without food
01/06/2011US20110002985 Abuse resistant drugs, method of use and method of making
01/06/2011US20110002975 Preoperative treatment of post operative pain
01/06/2011US20110002972 Neuroendocrine factors for treatment of degenerative diseases
01/06/2011US20110002957 Hapten-carrier conjugates for treating and preventing nicotine addiction
01/06/2011US20110002952 FUSED HETEROARYL MODULATORS OF GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-kappaB ACTIVITY AND USE THEREOF
01/06/2011US20110002945 Use of immunoglobulin heavy and light chains or fragments thereof to bind to aggregated amyloidogenic proteins
01/06/2011US20110002944 Compositions and Methods to Promote Neural Cell Growth
01/06/2011US20110002937 Method of making hybrid cells that express useful antibodies
01/06/2011US20110002931 Bispecific antibodies that bind to complement proteins
01/06/2011US20110002912 Composition
01/06/2011US20110002908 Treatment of a-galactosidase a deficiency
01/06/2011US20110002897 Directed differentiation of stem cells
01/06/2011US20110002888 Albumin Fusion Proteins
01/06/2011US20110002876 Multimeric VLA-4 Antagonists Comprising Polymer Moieties
01/06/2011US20110002855 Piperazinyl oxoalkyl tetrahydro-beta-carbolines and related analogues
01/06/2011US20110002851 Cationic Colloidal Carriers for Delivery of Active Agents to the Blood-Brain Barrier in the Course of Neuroinflammatory Diseases
01/06/2011CA2767130A1 Fluorinated derivatives of 3-hydroxypyridin-4-ones
01/06/2011CA2767029A1 A method of treatment of a neurological disorder
01/06/2011CA2766388A1 Benzoic acid, benzoic acid derivatives and heteroaryl carboxylic acid conjugates of hydrocodone, prodrugs, methods of making and use thereof
01/06/2011CA2766082A1 Use of one or a combination of phyto-cannabinoids in the treatment of epilepsy
01/06/2011CA2765836A1 Phenylethanoic acid, phenylpropanoic acid and phenylpropenoic acid conjugates and prodrugs of hydrocodone, methods of making and use thereof
01/06/2011CA2765475A1 2-carboxamide-7-piperazinyl-benzofuran derivatives 774
01/06/2011CA2764193A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics
01/06/2011CA2764185A1 Novel benzenesulfonamide compounds, method for synthesizing same, and use thereof in medicine as well as in cosmetics